[S02DA03, antipyrine, The metabolism of Fluorouracil can be decreased when combined with Antipyrine.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Streptokinase is combined with Fluorouracil.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Fluorouracil.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Fluorouracil.]
[L04AA27, fingolimod, Fluorouracil may increase the immunosuppressive activities of Fingolimod.]
[J01EC02, sulfadiazine, The metabolism of Fluorouracil can be decreased when combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Fluorouracil.]
[M04AB02, sulfinpyrazone, The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Fluorouracil.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Fluorouracil.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Fluorouracil.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Fluorouracil.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mercaptopurine.]
[N06DA01, tacrine, The metabolism of Fluorouracil can be decreased when combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Fluorouracil can be decreased when combined with Tamoxifen.]
[L01CB02, teniposide, The risk or severity of adverse effects can be increased when Teniposide is combined with Fluorouracil.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Fluorouracil.]
[B01AE07, dabigatran etexilate, The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Fluorouracil.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Fluorouracil.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Fluorouracil.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Fluorouracil.]
[N04BC07, apomorphine, The metabolism of Fluorouracil can be decreased when combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Thalidomide.]
[R03DA07, theobromine, The metabolism of Theobromine can be decreased when combined with Fluorouracil.]
[R03DA04, theophylline, The metabolism of Fluorouracil can be decreased when combined with Theophylline.]
[P02CA02, thiabendazole, The metabolism of Fluorouracil can be decreased when combined with Thiabendazole.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Eribulin.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Fluorouracil.]
[N05AC02, thioridazine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Thioridazine.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Fluorouracil.]
[B01AC05, ticlopidine, The metabolism of Fluorouracil can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The risk or severity of QTc prolongation can be increased when Timolol is combined with Fluorouracil.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Fluorouracil.]
[V04CA01, tolbutamide, The metabolism of Fluorouracil can be decreased when combined with Tolbutamide.]
[N06AF04, tranylcypromine, The metabolism of Fluorouracil can be decreased when combined with Tranylcypromine.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Fluorouracil.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Fluorouracil.]
[L01XF01, tretinoin, The metabolism of Fluorouracil can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Triamcinolone.]
[C03DB02, triamterene, The metabolism of Fluorouracil can be decreased when combined with Triamterene.]
[C03AA06, trichlormethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Fluorouracil.]
[N05AB06, trifluoperazine, The metabolism of Trifluoperazine can be decreased when combined with Fluorouracil.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Fluorouracil.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fluclorolone.]
[R03BA07, mometasone, The metabolism of Fluorouracil can be decreased when combined with Mometasone.]
[A03AA05, trimebutine, The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Fluorouracil.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Fluorouracil.]
[N03AC02, trimethadione, The metabolism of Fluorouracil can be decreased when combined with Trimethadione.]
[J01EA01, trimethoprim, The metabolism of Fluorouracil can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Fluorouracil.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Fluorouracil.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Fluorouracil.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Belimumab.]
[L01EX04, vandetanib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Vandetanib.]
[L02BX03, abiraterone, The serum concentration of Fluorouracil can be increased when it is combined with Abiraterone.]
[J05AG05, rilpivirine, The metabolism of Fluorouracil can be decreased when combined with Rilpivirine.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Fluorouracil.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Belatacept.]
[N03AX21, ezogabine, The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Fluorouracil.]
[B01AF01, rivaroxaban, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Fluorouracil.]
[R03AC18, indacaterol, The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fluorouracil.]
[B01AC24, ticagrelor, The risk or severity of bleeding can be increased when Ticagrelor is combined with Fluorouracil.]
[C08DA01, verapamil, The metabolism of Fluorouracil can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Fluorouracil can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Vinblastine.]
[L01CA02, vincristine, The risk or severity of adverse effects can be increased when Vincristine is combined with Fluorouracil.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Fluorouracil.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Fluorouracil.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Fluorouracil.]
[J05AF01, zidovudine, The metabolism of Fluorouracil can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Zuclopenthixol.]
[L01EC01, vemurafenib, The serum concentration of Fluorouracil can be increased when it is combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Brentuximab vedotin.]
[L01ED01, crizotinib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Crizotinib.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Fluorouracil.]
[R03DC01, zafirlukast, The metabolism of Zafirlukast can be decreased when combined with Fluorouracil.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Fluorouracil.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ziprasidone.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Fluorouracil.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Fluorouracil.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Fluorouracil.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Fluorouracil.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluorouracil.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Fluorouracil.]
[J02AC03, voriconazole, The metabolism of Voriconazole can be decreased when combined with Fluorouracil.]
[S01FA01, atropine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Atropine.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Fluorouracil.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Fluorouracil.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Azathioprine.]
[L01BC05, gemcitabine, The serum concentration of Fluorouracil can be increased when it is combined with Gemcitabine.]
[G04BE10, avanafil, Avanafil may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Fluorouracil.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluorouracil.]
[L01FD02, pertuzumab, The risk or severity of cardiotoxicity can be increased when Fluorouracil is combined with Pertuzumab.]
[A08AA11, lorcaserin, The metabolism of Fluorouracil can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Fluorouracil.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Carfilzomib.]
[V03AX03, cobicistat, Cobicistat may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[L02BB04, enzalutamide, The metabolism of Fluorouracil can be decreased when combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Fluorouracil can be decreased when combined with Bosutinib.]
[L04AA31, teriflunomide, The serum concentration of Fluorouracil can be decreased when it is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Fluorouracil.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Aldosterone.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[C01AA01, acetyldigitoxin, Acetyldigitoxin may decrease the cardiotoxic activities of Fluorouracil.]
[J05AE04, nelfinavir, Nelfinavir may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Bendamustine.]
[N04BD02, rasagiline, The metabolism of Rasagiline can be decreased when combined with Fluorouracil.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Fluorouracil.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Fluorouracil.]
[L04AA29, tofacitinib, Fluorouracil may increase the immunosuppressive activities of Tofacitinib.]
[N02CC03, zolmitriptan, The metabolism of Fluorouracil can be decreased when combined with Zolmitriptan.]
[L01EX07, cabozantinib, The metabolism of Fluorouracil can be decreased when combined with Cabozantinib.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Fluorouracil.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Fluorouracil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Fluorouracil.]
[B01AF02, apixaban, The metabolism of Fluorouracil can be decreased when combined with Apixaban.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Bedaquiline.]
[C04AX11, bencyclane, The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Fluorouracil.]
[C03AA01, bendroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Fluorouracil.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Fluorouracil.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dimethyl fumarate.]
[J01MA15, gemifloxacin, The metabolism of Fluorouracil can be decreased when combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The metabolism of Fluorouracil can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, The metabolism of Fluorouracil can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Fluorouracil can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Everolimus.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Fluorouracil.]
[L01EC02, dabrafenib, The serum concentration of Fluorouracil can be decreased when it is combined with Dabrafenib.]
[L01EE01, trametinib, The metabolism of Fluorouracil can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Benzyl alcohol.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[N06AX28, levomilnacipran, The metabolism of Fluorouracil can be decreased when combined with Levomilnacipran.]
[C08EA02, bepridil, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Bepridil.]
[C02KX05, riociguat, The metabolism of Fluorouracil can be decreased when combined with Riociguat.]
[L03AA14, lipegfilgrastim, Fluorouracil may increase the myelosuppressive activities of Lipegfilgrastim.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ibrutinib.]
[N06AX26, vortioxetine, The metabolism of Fluorouracil can be decreased when combined with Vortioxetine.]
[J05AP05, simeprevir, The metabolism of Fluorouracil can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The metabolism of Fluorouracil can be decreased when combined with Dapagliflozin.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Fluorouracil.]
[A16AA07, metreleptin, The metabolism of Fluorouracil can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Fluorouracil can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The metabolism of Fluorouracil can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Fluorouracil can be decreased when combined with Betaxolol.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Fluorouracil.]
[V03AB34, fomepizole, The metabolism of Fluorouracil can be decreased when combined with Fomepizole.]
[C10AB02, bezafibrate, The metabolism of Fluorouracil can be decreased when combined with Bezafibrate.]
[L04AC11, siltuximab, The metabolism of Fluorouracil can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ceritinib.]
[B01AC26, vorapaxar, The risk or severity of bleeding can be increased when Vorapaxar is combined with Fluorouracil.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Vedolizumab.]
[A03BA03, hyoscyamine, The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Fluorouracil.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Fluorouracil.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Belinostat.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Idelalisib.]
[N07XX08, tafamidis, The serum concentration of Fluorouracil can be increased when it is combined with Tafamidis.]
[R03AC19, olodaterol, The metabolism of Fluorouracil can be decreased when combined with Olodaterol.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Peginterferon beta-1a.]
[A16AX10, eliglustat, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Eliglustat.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Decitabine.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pirfenidone.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Blinatumomab.]
[J05AP09, dasabuvir, The metabolism of Fluorouracil can be decreased when combined with Dasabuvir.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Olaparib.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Fluorouracil.]
[B01AF03, edoxaban, The risk or severity of bleeding can be increased when Edoxaban is combined with Fluorouracil.]
[N06AX11, mirtazapine, The metabolism of Fluorouracil can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Fluorouracil can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Palbociclib.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Lenvatinib.]
[L01XH03, panobinostat, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Panobinostat.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[N02BE01, acetaminophen, The metabolism of Fluorouracil can be decreased when combined with Acetaminophen.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluorouracil.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Fluorouracil is combined with Tioclomarol.]
[C01EB17, ivabradine, Ivabradine may increase the QTc-prolonging activities of Fluorouracil.]
[J05AP06, asunaprevir, The metabolism of Fluorouracil can be decreased when combined with Asunaprevir.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Fluorouracil.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[A02BC03, lansoprazole, The metabolism of Fluorouracil can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Fluorouracil.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Fluorouracil can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Fluorouracil can be decreased when it is combined with Osimertinib.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[B01AC27, selexipag, The metabolism of Fluorouracil can be decreased when combined with Selexipag.]
[A10BB31, acetohexamide, The metabolism of Acetohexamide can be decreased when combined with Fluorouracil.]
[G04CA01, alfuzosin, The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Fluorouracil.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Fluorouracil.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Fluorouracil.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ixekizumab.]
[L01XX52, venetoclax, Venetoclax may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be decreased when combined with Fluorouracil.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Fluorouracil.]
[A05AA04, obeticholic acid, The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Fluorouracil.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Bupivacaine.]
[C07AA19, bupranolol, The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Fluorouracil.]
[N07BC01, buprenorphine, The metabolism of Fluorouracil can be decreased when combined with Buprenorphine.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Fluorouracil.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Arsenic trioxide.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Artemether.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Fluorouracil.]
[S01GX07, azelastine, The metabolism of Fluorouracil can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Fluorouracil can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Fluorouracil.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Brodalumab.]
[L01EF02, ribociclib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ribociclib.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Fluorouracil.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Fluorouracil.]
[N07XX16, deutetrabenazine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Fluorouracil.]
[N06BC01, caffeine, The metabolism of Fluorouracil can be decreased when combined with Caffeine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Oxybuprocaine.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Fluorouracil.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Linezolid.]
[L04AB02, infliximab, The metabolism of Fluorouracil can be increased when combined with Infliximab.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Fluorouracil.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Sarilumab.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Fluorouracil.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Fluorouracil.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Guselkumab.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Fluorouracil.]
[L01XX59, enasidenib, The metabolism of Fluorouracil can be decreased when combined with Enasidenib.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Vorinostat.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Fluorouracil can be decreased when combined with Efavirenz.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Fluorouracil.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Fluorouracil.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Fluorouracil.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Fluorouracil.]
[J05AX18, letermovir, The metabolism of Fluorouracil can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Butriptyline.]
[C01AA02, acetyldigoxins, Acetyldigoxin may decrease the cardiotoxic activities of Fluorouracil.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Capsaicin.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Fluorouracil.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Macimorelin.]
[L02BB05, apalutamide, The metabolism of Fluorouracil can be decreased when combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Carbamazepine.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Carbinoxamine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluorouracil.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Fluorouracil.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[N03AX24, cannabidiol, The metabolism of Fluorouracil can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Fluorouracil can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Baricitinib.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Encorafenib.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Fluorouracil.]
[C07AB08, celiprolol, The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Fluorouracil.]
[H01CC03, elagolix, The metabolism of Fluorouracil can be decreased when combined with Elagolix.]
[L01XX62, ivosidenib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Fluorouracil can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Fluorouracil can be increased when combined with Tecovirimat.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Fluorouracil.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Fluorouracil.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Fluorouracil.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Fluorouracil.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Fluorouracil.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Inotersen is combined with Fluorouracil.]
[L04AA39, emapalumab, The metabolism of Fluorouracil can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Fluorouracil.]
[L01EX13, gilteritinib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Gilteritinib.]
[L01XJ03, glasdegib, The metabolism of Fluorouracil can be decreased when combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Amifampridine.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ravulizumab.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Fluorouracil.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Fluorouracil.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Fluorouracil.]
[P02BX04, triclabendazole, The metabolism of Fluorouracil can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Fluorouracil.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Fluorouracil.]
[J01FA09, clarithromycin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Fluorouracil.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Fluorouracil can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Fluorouracil can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Risankizumab.]
[L01EM03, alpelisib, The metabolism of Fluorouracil can be decreased when combined with Alpelisib.]
[L02BB06, darolutamide, The serum concentration of Fluorouracil can be increased when it is combined with Darolutamide.]
[C03BX03, cicletanine, The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Fluorouracil.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Fluorouracil.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Upadacitinib.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Entrectinib.]
[N07XX11, pitolisant, Fluorouracil may increase the QTc-prolonging activities of Pitolisant.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Fluorouracil.]
[N04CX01, istradefylline, The metabolism of Fluorouracil can be decreased when combined with Istradefylline.]
[C03AA09, cyclothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Fluorouracil.]
[A10AE03, insulin, regular, pork, The metabolism of Fluorouracil can be increased when combined with Insulin pork.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Deflazacort.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Fluorouracil.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Trastuzumab emtansine.]
[N02CC08, lasmiditan, The serum concentration of Fluorouracil can be increased when it is combined with Lasmiditan.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Diroximel fumarate.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Fluorouracil.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Fluorouracil.]
[N03AX25, cenobamate, The metabolism of Fluorouracil can be increased when combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Fluorouracil can be increased when it is combined with Givosiran.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Fluorouracil.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dexchlorpheniramine.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Fluorouracil.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Teprotumumab.]
[M01AX21, diacetylrhein, The metabolism of Fluorouracil can be decreased when combined with Diacerein.]
[S01AE06, gatifloxacin, The metabolism of Fluorouracil can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The serum concentration of Fluorouracil can be increased when it is combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Fluorouracil.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Fluorouracil.]
[L04AA38, ozanimod, The metabolism of Fluorouracil can be decreased when combined with Ozanimod.]
[L01EE04, selumetinib, The metabolism of Fluorouracil can be decreased when combined with Selumetinib.]
[N02CC06, eletriptan, The metabolism of Fluorouracil can be increased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Fluorouracil can be decreased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Fluorouracil can be decreased when combined with Bexarotene.]
[C01BD07, dronedarone, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dronedarone.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Fluorouracil.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluorouracil.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Fluorouracil.]
[L01EH03, tucatinib, The metabolism of Fluorouracil can be decreased when combined with Tucatinib.]
[L01EX17, capmatinib, The serum concentration of Fluorouracil can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fluprednidene.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Fluorouracil can be increased when it is combined with Selpercatinib.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Fluorouracil.]
[N05CM02, chlormethiazole, The metabolism of Fluorouracil can be decreased when combined with Clomethiazole.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Fluorouracil is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Dyclonine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Stepronin.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Ebastine is combined with Fluorouracil.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Fluorouracil.]
[L04AC19, satralizumab, The serum concentration of Fluorouracil can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The metabolism of Fluorouracil can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The metabolism of Fluorouracil can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Fluorouracil.]
[R06AB04, chlorpheniramine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Fluorouracil.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Fluorouracil.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Fluorouracil.]
[M03BB03, chlorzoxazone, The metabolism of Fluorouracil can be decreased when combined with Chlorzoxazone.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Fluorouracil.]
[M02AA06, etofenamate, The therapeutic efficacy of Etofenamate can be decreased when used in combination with Fluorouracil.]
[B06AC06, berotralstat, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Berotralstat.]
[A16AX20, lonafarnib, The serum concentration of Lonafarnib can be increased when it is combined with Fluorouracil.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fludarabine.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Relugolix is combined with Fluorouracil.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Fluorouracil can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, Tepotinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[V03AF12, trilaciclib, The metabolism of Fluorouracil can be increased when combined with Trilaciclib.]
[N03AX10, felbamate, The risk or severity of QTc prolongation can be increased when Felbamate is combined with Fluorouracil.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Fluorouracil.]
[J01MB07, flumequine, The metabolism of Fluorouracil can be decreased when combined with Flumequine.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Fluorouracil.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fluocinolone acetonide.]
[R03CC15, formoterol, The metabolism of Fluorouracil can be decreased when combined with Formoterol.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Fluorouracil.]
[S01LA08, bevacizumab, The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Fluorouracil.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The serum concentration of Fluorouracil can be increased when it is combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The serum concentration of Fluorouracil can be increased when it is combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Fluorouracil can be decreased when combined with Cinnarizine.]
[J01MB06, cinoxacin, The metabolism of Fluorouracil can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Fluorouracil can be increased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Fluorouracil can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Fluorouracil.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Citalopram.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pegcetacoplan.]
[H01AC07, somapacitan, The metabolism of Fluorouracil can be increased when combined with Somapacitan.]
[C03DA05, finerenone, The metabolism of Fluorouracil can be decreased when combined with Finerenone.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Belumosudil.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fexinidazole.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Anifrolumab.]
[H01AC09, lonapegsomatropin, The metabolism of Fluorouracil can be increased when combined with Lonapegsomatropin.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Mobocertinib.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Clemastine.]
[A10BB12, glimepiride, The metabolism of Glimepiride can be decreased when combined with Fluorouracil.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Fluorouracil.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Fluorouracil.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Fluorouracil.]
[C10AB01, clofibrate, The metabolism of Fluorouracil can be decreased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Fluorouracil can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Fluorouracil can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Fluorouracil.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Fluorouracil.]
[C01EB24, mavacamten, The metabolism of Mavacamten can be decreased when combined with Fluorouracil.]
[J02AC06, oteseconazole, The serum concentration of Fluorouracil can be increased when it is combined with Oteseconazole.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Deucravacitinib.]
[H01CC04, linzagolix, The serum concentration of Fluorouracil can be increased when it is combined with Linzagolix.]
[A04AA01, ondansetron, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Granisetron.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Fluorouracil is combined with Clozapine.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Fluorouracil can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Fluorouracil can be increased when combined with Bimekizumab.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of QTc prolongation can be increased when Desflurane is combined with Fluorouracil.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Fluorouracil.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Nelarabine.]
[J01FA15, telithromycin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Indobufen is combined with Fluorouracil.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Desloratadine.]
[M01AH03, valdecoxib, The metabolism of Valdecoxib can be decreased when combined with Fluorouracil.]
[C01AA06, lanatoside C, Lanatoside C may decrease the cardiotoxic activities of Fluorouracil.]
[N02CC05, almotriptan, The metabolism of Fluorouracil can be decreased when combined with Almotriptan.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Fluorouracil.]
[J02AC02, itraconazole, Itraconazole may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Fluorouracil.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Fluorouracil.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Emedastine.]
[L01EA01, imatinib, The metabolism of Fluorouracil can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fluorouracil.]
[C08CA09, lacidipine, The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Fluorouracil.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fluorouracil.]
[N03AX09, lamotrigine, The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Fluorouracil.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Fluorouracil.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Lomefloxacin.]
[R06AX13, loratadine, The metabolism of Fluorouracil can be decreased when combined with Loratadine.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Meprednisone.]
[R06AD07, mequitazine, The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Fluorouracil.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Adenosine.]
[R06AE03, cyclizine, The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Fluorouracil.]
[N05AD03, metylperon, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Melperone.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Fluorouracil.]
[C03AA07, cyclopenthiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Fluorouracil.]
[L01AA01, cyclophosphamide, The metabolism of Fluorouracil can be increased when combined with Cyclophosphamide.]
[S01XA18, cyclosporine, Fluorouracil may increase the immunosuppressive activities of Cyclosporine.]
[N06BA07, modafinil, The metabolism of Fluorouracil can be increased when combined with Armodafinil.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Fluorouracil.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Fluorouracil.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Fluorouracil.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Fluorouracil can be decreased when combined with Entecavir.]
[G04BE09, vardenafil, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Fluorouracil.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Fluorouracil.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dactinomycin.]
[M03CA01, dantrolene, The therapeutic efficacy of Dantrolene can be decreased when used in combination with Fluorouracil.]
[J04BA02, dapsone, The metabolism of Fluorouracil can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Daunorubicin.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Fluorouracil.]
[M01AX01, nabumetone, The metabolism of Fluorouracil can be decreased when combined with Nabumetone.]
[L02BB02, nilutamide, The metabolism of Fluorouracil can be decreased when combined with Nilutamide.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Fluorouracil.]
[B01AX05, fondaparinux, The risk or severity of bleeding can be increased when Fondaparinux is combined with Fluorouracil.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluorouracil.]
[N06AB10, escitalopram, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Fluorouracil.]
[N06AA01, desipramine, The risk or severity of QTc prolongation can be increased when Desipramine is combined with Fluorouracil.]
[C01AA07, deslanoside, Deslanoside may decrease the cardiotoxic activities of Fluorouracil.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Desoximetasone.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluorouracil.]
[S03BA01, dexamethasone, The metabolism of Fluorouracil can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Fluorouracil can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Fluorouracil.]
[L04AB04, adalimumab, The metabolism of Fluorouracil can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[N06BA02, dextroamphetamine, The metabolism of Fluorouracil can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Fluorouracil.]
[N03AC01, paramethadione, The metabolism of Fluorouracil can be decreased when combined with Paramethadione.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Fluorouracil.]
[B01AC04, clopidogrel, The metabolism of Fluorouracil can be decreased when combined with Clopidogrel.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Fluorouracil.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Fluorouracil.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Cinchocaine.]
[S01BC03, diclofenac, The metabolism of Fluorouracil can be decreased when combined with Diclofenac.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Fluorouracil.]
[A03AX04, pinaverium, The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Fluorouracil.]
[A10BG03, pioglitazone, The metabolism of Fluorouracil can be decreased when combined with Pioglitazone.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Fluorouracil can be decreased when combined with Erlotinib.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pirarubicin.]
[L02AA01, diethylstilbestrol, The metabolism of Fluorouracil can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The risk or severity of QTc prolongation can be increased when Isradipine is combined with Fluorouracil.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Difluocortolone.]
[C01AA04, digitoxin, Digitoxin may decrease the cardiotoxic activities of Fluorouracil.]
[C01AA05, digoxin, Digoxin may decrease the cardiotoxic activities of Fluorouracil.]
[C02DB01, dihydralazine, The metabolism of Fluorouracil can be decreased when combined with Dihydralazine.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Fluorouracil.]
[N02AA03, hydromorphone, The metabolism of Hydromorphone can be decreased when combined with Fluorouracil.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Fluorouracil.]
[J05AE08, atazanavir, The metabolism of Fluorouracil can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Fluorouracil can be decreased when combined with Treprostinil.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Fluorouracil can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dimenhydrinate.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Fluorouracil.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Proparacaine.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Fluorouracil.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Fluorouracil.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Dipyridamole is combined with Fluorouracil.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Fluorouracil.]
[A03FA02, cisapride, The metabolism of Fluorouracil can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Sirolimus.]
[C01BA03, disopyramide, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Disopyramide.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Natalizumab.]
[P03AA04, disulfiram, The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Fluorouracil.]
[S02AA12, rifamycin SV, The metabolism of Fluorouracil can be decreased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Fluorouracil can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The metabolism of Riluzole can be decreased when combined with Fluorouracil.]
[N05AX08, risperidone, The risk or severity of QTc prolongation can be increased when Risperidone is combined with Fluorouracil.]
[R06AE09, levocetirizine, The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Fluorouracil.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Fluorouracil.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Ropivacaine.]
[J01MB01, rosoxacin, The metabolism of Fluorouracil can be decreased when combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Sunitinib.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Fluorouracil.]
[S01BC05, ketorolac, The metabolism of Fluorouracil can be decreased when combined with Ketorolac.]
[C01EB18, ranolazine, The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Fluorouracil.]
[R03AC12, salmeterol, The metabolism of Fluorouracil can be decreased when combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Fluorouracil can be decreased when combined with Domperidone.]
[N06AA16, dothiepin, The metabolism of Fluorouracil can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Fluorouracil.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Doxorubicin.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Fluorouracil.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Fluorouracil.]
[N01AB08, sevoflurane, The metabolism of Fluorouracil can be decreased when combined with Sevoflurane.]
[N05AD08, droperidol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Fluorouracil.]
[C10AA01, simvastatin, The metabolism of Fluorouracil can be decreased when combined with Simvastatin.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Sultopride.]
[C07AB13, talinolol, The risk or severity of QTc prolongation can be increased when Talinolol is combined with Fluorouracil.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Corticotropin.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Temozolomide.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Fluorouracil.]
[D01BA02, terbinafine, The metabolism of Fluorouracil can be decreased when combined with Terbinafine.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Terodiline.]
[N06BA09, atomoxetine, The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Fluorouracil.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Toremifene.]
[C03CA04, torsemide, The metabolism of Fluorouracil can be decreased when combined with Torasemide.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Fluorouracil.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Trilostane.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Fluorouracil.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Trofosfamide.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Fluorouracil.]
[J01MA04, enoxacin, The metabolism of Fluorouracil can be decreased when combined with Enoxacin.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Fluorouracil.]
[S01GX10, epinastine, The risk or severity of QTc prolongation can be increased when Epinastine is combined with Fluorouracil.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Fluorouracil which could result in a lower serum level and potentially a reduction in efficacy.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Fluorouracil.]
[N05CF02, zolpidem, The metabolism of Fluorouracil can be decreased when combined with Zolpidem.]
[N03AX15, zonisamide, The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Fluorouracil.]
[N05CF01, zopiclone, The metabolism of Fluorouracil can be decreased when combined with Zopiclone.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Fluorouracil.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Fluorouracil.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Carboplatin.]
[B01AC11, iloprost, The risk or severity of bleeding can be increased when Iloprost is combined with Fluorouracil.]
[C01BG01, moricizine, The risk or severity of QTc prolongation can be increased when Moricizine is combined with Fluorouracil.]
[N03AG01, valproic acid, The metabolism of Fluorouracil can be decreased when combined with Valproic acid.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Fluorouracil.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Fluorouracil.]
[G03CA03, estradiol, The metabolism of Fluorouracil can be decreased when combined with Estradiol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Estramustine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Fluorouracil can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, The metabolism of Fluorouracil can be decreased when combined with Ethambutol.]
[R03BA05, fluticasone, The metabolism of Fluorouracil can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluorouracil can be decreased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The metabolism of Fluorouracil can be decreased when combined with Ethinylestradiol.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ibutilide.]
[N03AD01, ethosuximide, The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Fluorouracil.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be decreased when used in combination with Fluorouracil.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Etidocaine.]
[L01CB01, etoposide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Etoposide.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Fluorouracil.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Fluorouracil.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Fluorouracil.]
[R06AX11, astemizole, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Astemizole.]
[R06AX12, terfenadine, The metabolism of Fluorouracil can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Fluorouracil.]
[N06AB08, fluvoxamine, The metabolism of Fluorouracil can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, The metabolism of Fluorouracil can be decreased when combined with Tocainide.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Encainide is combined with Fluorouracil.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluorouracil.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Fluorouracil.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[B05AA05, dextran, The risk or severity of bleeding can be increased when Dextran is combined with Fluorouracil.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Fluorouracil.]
[A02BA03, famotidine, The metabolism of Fluorouracil can be decreased when combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Fluorouracil can be increased when combined with Albendazole.]
[C08CA02, felodipine, The metabolism of Fluorouracil can be decreased when combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Fendiline.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Fluorouracil.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Fluorouracil.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Fluorouracil.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Clofarabine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Fluorouracil.]
[C01BC04, flecainide, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Flecainide.]
[J02AC01, fluconazole, The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Fluorouracil.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fludrocortisone.]
[N07CA03, flunarizine, The metabolism of Fluorouracil can be decreased when combined with Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Fluorouracil can be decreased when combined with Flunitrazepam.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fluocinonide.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Ethanol can be decreased when combined with Fluorouracil.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Fluorouracil.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fluorouracil.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Antilymphocyte immunoglobulin (horse).]
[S01AA13, fusidic acid, Fusidic acid may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[J01MB04, pipemidic acid, The metabolism of Fluorouracil can be decreased when combined with Pipemidic acid.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Fluorouracil.]
[R03BA09, fluticasone furoate, The metabolism of Fluorouracil can be decreased when combined with Fluticasone furoate.]
[N06AB03, fluoxetine, The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Fluorouracil.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Flupentixol.]
[N05CD01, flurazepam, The metabolism of Fluorouracil can be decreased when combined with Flurazepam.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Fluorouracil.]
[N05AG01, fluspirilene, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Fluspirilene.]
[L02BB01, flutamide, The metabolism of Fluorouracil can be decreased when combined with Flutamide.]
[V04CX02, folic acid, The risk or severity of adverse effects can be increased when Folic acid is combined with Fluorouracil.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Fluorouracil.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be decreased when used in combination with Fluorouracil.]
[N05CF04, eszopiclone, The metabolism of Fluorouracil can be decreased when combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Amisulpride.]
[N06DA04, galantamine, The risk or severity of QTc prolongation can be increased when Galantamine is combined with Fluorouracil.]
[C08DA02, gallopamil, The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Fluorouracil.]
[C10AB04, gemfibrozil, The metabolism of Fluorouracil can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Telavancin.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Fluorouracil.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dasatinib.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Fluorouracil.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Fluorouracil.]
[N03AD03, methsuximide, The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Fluorouracil.]
[L01EH01, lapatinib, The metabolism of Fluorouracil can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Fluorouracil.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Fluorouracil.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Fluorouracil.]
[N05CM18, dexmedetomidine, The metabolism of Fluorouracil can be decreased when combined with Dexmedetomidine.]
[C01BD04, dofetilide, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dofetilide.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Fluorouracil.]
[L01EX02, sorafenib, The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Fluorouracil.]
[C07AB09, esmolol, The risk or severity of QTc prolongation can be increased when Esmolol is combined with Fluorouracil.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Fluorouracil.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fluorouracil.]
[P01BX01, halofantrine, The metabolism of Fluorouracil can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Haloperidol.]
[N01AB01, halothane, The metabolism of Fluorouracil can be decreased when combined with Halothane.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Fluorouracil.]
[N05AH04, quetiapine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Quetiapine.]
[L01CE02, irinotecan, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Irinotecan.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Fluorouracil.]
[C09CA01, losartan, The metabolism of Fluorouracil can be decreased when combined with Losartan.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be decreased when used in combination with Fluorouracil.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Fluorouracil.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Fluorouracil.]
[J05AG01, nevirapine, The metabolism of Fluorouracil can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Fluorouracil can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of bleeding can be increased when Nimesulide is combined with Fluorouracil.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Oxatomide.]
[C03AA03, hydrochlorothiazide, The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Fluorouracil.]
[S02BA01, hydrocortisone, The metabolism of Fluorouracil can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Fluorouracil.]
[P01BA02, hydroxychloroquine, The metabolism of Fluorouracil can be decreased when combined with Hydroxychloroquine.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Fluorouracil can be increased when combined with Rifabutin.]
[R02AX02, ibuprofen, The metabolism of Fluorouracil can be decreased when combined with Ibuprofen.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Fluorouracil.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Fluorouracil can be increased when combined with Ifosfamide.]
[H01AC02, somatrem, The metabolism of Fluorouracil can be increased when combined with Somatrem.]
[N06AA02, imipramine, The metabolism of Fluorouracil can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Fluorouracil.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Terlipressin.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Tixocortol.]
[M03BX02, tizanidine, The metabolism of Tizanidine can be decreased when combined with Fluorouracil.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Topotecan.]
[C03BA11, indapamide, The risk or severity of QTc prolongation can be increased when Indapamide is combined with Fluorouracil.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Fluorouracil.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Fluorouracil.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Fluorouracil.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Articaine.]
[A10BH01, sitagliptin, The metabolism of Fluorouracil can be decreased when combined with Sitagliptin.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Fluorouracil.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Fluorouracil.]
[C10AA06, cerivastatin, The metabolism of Fluorouracil can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Anagrelide.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Fluorouracil.]
[J05AB13, penciclovir, The metabolism of Fluorouracil can be decreased when combined with Penciclovir.]
[N01AB06, isoflurane, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Fluorouracil.]
[J04AC01, isoniazid, The metabolism of Fluorouracil can be decreased when combined with Isoniazid.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Fluorouracil.]
[H01AC01, somatropin, The metabolism of Fluorouracil can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Fluorouracil can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Fluorouracil can be decreased when combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of bleeding can be increased when Ketanserin is combined with Fluorouracil.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Fluorouracil.]
[J02AB02, ketoconazole, The metabolism of Fluorouracil can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Fluorouracil can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The metabolism of Fluorouracil can be decreased when combined with Ketoprofen.]
[V03AC03, deferasirox, The serum concentration of Fluorouracil can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Fluorouracil can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Mizolastine.]
[J01MB02, nalidixic acid, The metabolism of Fluorouracil can be decreased when combined with Nalidixic acid.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Amantadine is combined with Fluorouracil.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Fluorouracil.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Fluorouracil.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Fluorouracil.]
[N06BA13, armodafinil, The metabolism of Fluorouracil can be increased when combined with Armodafinil.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Lomustine.]
[A07DA03, loperamide, The metabolism of Fluorouracil can be decreased when combined with Loperamide.]
[C10AA02, lovastatin, The metabolism of Fluorouracil can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Fluorouracil.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Temsirolimus.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pralatrexate.]
[L01EA03, nilotinib, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Nilotinib.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Fluorouracil.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Meclofenamic acid can be decreased when used in combination with Fluorouracil.]
[C01AA08, medigoxin, Metildigoxin may decrease the cardiotoxic activities of Fluorouracil.]
[P01BC02, mefloquine, The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Fluorouracil.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Fluorouracil.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Fluorouracil.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Fluorouracil.]
[N05CH01, melatonin, The metabolism of Melatonin can be decreased when combined with Fluorouracil.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Melphalan.]
[N06DX01, memantine, The metabolism of Fluorouracil can be decreased when combined with Memantine.]
[N03AB04, mephenytoin, The metabolism of Fluorouracil can be decreased when combined with Mephenytoin.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Mepivacaine.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of QTc prolongation can be increased when Methadone is combined with Fluorouracil.]
[H03BB02, methimazole, The metabolism of Fluorouracil can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pemetrexed.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Methotrexate is combined with Fluorouracil.]
[N05AA02, methotrimeprazine, The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Fluorouracil.]
[D05BA02, methoxsalen, The metabolism of Fluorouracil can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Fluorouracil can be decreased when combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Fluorouracil.]
[V04CG05, methylene blue, The metabolism of Fluorouracil can be decreased when combined with Methylene blue.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Fluorouracil.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Methylprednisolone.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Fluorouracil.]
[P01AB01, metronidazole, The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Fluorouracil can be decreased when combined with Metyrapone.]
[C01BB02, mexiletine, The metabolism of Fluorouracil can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Fluorouracil.]
[S02AA13, miconazole, The metabolism of Fluorouracil can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Fluorouracil can be decreased when combined with Aminophenazone.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Fluorouracil.]
[G03XB01, mifepristone, The serum concentration of Fluorouracil can be increased when it is combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Fluorouracil.]
[C09CA03, valsartan, The metabolism of Valsartan can be decreased when combined with Fluorouracil.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluorouracil.]
[C01BD01, amiodarone, The metabolism of Amiodarone can be decreased when combined with Fluorouracil.]
[N06AA09, amitriptyline, The metabolism of Fluorouracil can be decreased when combined with Amitriptyline.]
[N02AA01, morphine, The metabolism of Fluorouracil can be decreased when combined with Morphine.]
[L04AB05, certolizumab pegol, The metabolism of Fluorouracil can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Fluorouracil can be decreased when combined with Eltrombopag.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ofatumumab.]
[L01EX03, pazopanib, The metabolism of Fluorouracil can be decreased when combined with Pazopanib.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mycophenolic acid.]
[P01BA06, amodiaquine, The metabolism of Fluorouracil can be decreased when combined with Amodiaquine.]
[G03XC01, raloxifene, The metabolism of Fluorouracil can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Fluorouracil.]
[N03AB05, fosphenytoin, The serum concentration of Fosphenytoin can be increased when it is combined with Fluorouracil.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Fluorouracil.]
[J01CF06, nafcillin, The metabolism of Fluorouracil can be increased when combined with Nafcillin.]
[L04AC03, anakinra, The metabolism of Fluorouracil can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Fluorouracil can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The metabolism of Fluorouracil can be decreased when combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Fluorouracil can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Fluorouracil.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Fluorouracil.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Docetaxel.]
[L02BG04, letrozole, The metabolism of Fluorouracil can be decreased when combined with Letrozole.]
[S03AA01, neomycin, Neomycin can cause a decrease in the absorption of Fluorouracil resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10BX02, repaglinide, The metabolism of Fluorouracil can be decreased when combined with Repaglinide.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Levosimendan.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Fluorouracil.]
[N05AX14, iloperidone, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Iloperidone.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Fluorouracil can be decreased when combined with Febuxostat.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Fluorouracil.]
[C08CA04, nicardipine, The metabolism of Fluorouracil can be decreased when combined with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Fluorouracil can be decreased when combined with Niclosamide.]
[N07BA01, nicotine, The metabolism of Fluorouracil can be decreased when combined with Nicotine.]
[C08CA05, nifedipine, The metabolism of Fluorouracil can be decreased when combined with Nifedipine.]
[C08CA06, nimodipine, The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Fluorouracil.]
[C08CA08, nitrendipine, The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Fluorouracil.]
[J01XE01, nitrofurantoin, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Fluorouracil.]
[S01AE02, norfloxacin, The metabolism of Fluorouracil can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, The metabolism of Bosentan can be decreased when combined with Fluorouracil.]
[N06AA10, nortriptyline, The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Fluorouracil.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Fluorouracil.]
[L03AB07, interferon beta-1a, The metabolism of Fluorouracil can be decreased when combined with Interferon beta-1a.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Fluorouracil.]
[H01CB02, octreotide, The risk or severity of QTc prolongation can be increased when Octreotide is combined with Fluorouracil.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Fluorouracil can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Fluorouracil can be decreased when combined with Omeprazole.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Fluorouracil.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Fluorouracil.]
[C01AC01, ouabain, Ouabain may decrease the cardiotoxic activities of Fluorouracil.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Fluorouracil.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Fluorouracil.]
[N05AH05, asenapine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Asenapine.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Fluorouracil.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Papaverine.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Paramethasone.]
[J01MA03, pefloxacin, The metabolism of Fluorouracil can be decreased when combined with Pefloxacin.]
[N05AG03, penfluridol, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Penfluridol.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Penicillamine.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluorouracil.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluorouracil.]
[N05CA01, pentobarbital, The metabolism of Fluorouracil can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pentostatin.]
[C04AD03, pentoxifylline, The metabolism of Pentoxifylline can be decreased when combined with Fluorouracil.]
[C08EX02, perhexiline, The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Fluorouracil.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Fluorouracil.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Fluorouracil.]
[N02BE03, phenacetin, The metabolism of Fluorouracil can be decreased when combined with Phenacetin.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Fluorouracil is combined with Phenindione.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Fluorouracil.]
[N03AA02, phenobarbital, The metabolism of Fluorouracil can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Fluorouracil.]
[M02AA01, phenylbutazone, The metabolism of Phenylbutazone can be decreased when combined with Fluorouracil.]
[S01GA05, phenylephrine, The metabolism of Fluorouracil can be increased when combined with Phenylephrine.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be increased when it is combined with Fluorouracil.]
[L04AB06, golimumab, The metabolism of Fluorouracil can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Levofloxacin.]
[C08CX01, mibefradil, The metabolism of Fluorouracil can be decreased when combined with Mibefradil.]
[S01EB01, pilocarpine, The metabolism of Fluorouracil can be decreased when combined with Pilocarpine.]
[N05AG02, pimozide, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Pimozide.]
[C10AA05, atorvastatin, The metabolism of Fluorouracil can be decreased when combined with Atorvastatin.]
[J05AE01, saquinavir, The metabolism of Fluorouracil can be decreased when combined with Saquinavir.]
[S01BC06, piroxicam, The metabolism of Fluorouracil can be decreased when combined with Piroxicam.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Grepafloxacin.]
[C09CA04, irbesartan, The metabolism of Fluorouracil can be decreased when combined with Irbesartan.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Fluorouracil.]
[D05AX05, tazarotene, The metabolism of Fluorouracil can be decreased when combined with Tazarotene.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Fluorouracil.]
[A10BG02, rosiglitazone, The metabolism of Fluorouracil can be decreased when combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Fluorouracil can be decreased when combined with Anastrozole.]
[A03AE01, alosetron, The metabolism of Fluorouracil can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Fluorouracil can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Fluorouracil.]
[J05AE03, ritonavir, The metabolism of Fluorouracil can be decreased when combined with Ritonavir.]
[C10AA08, pitavastatin, The metabolism of Fluorouracil can be decreased when combined with Pitavastatin.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Fluorouracil.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Fluorouracil.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Prednisolone.]
[H02AB07, prednisone, The metabolism of Fluorouracil can be increased when combined with Prednisone.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Antazoline.]
[C01DX02, prenylamine, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Prenylamine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Fluorouracil can be increased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Fluorouracil can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Fluorouracil can be increased when combined with Probenecid.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Probucol.]
[C01BA02, procainamide, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Procainamide.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Fluorouracil can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Fluorouracil.]
[G03DA04, progesterone, The metabolism of Fluorouracil can be increased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Fluorouracil can be decreased when combined with Promazine.]
[R06AD02, promethazine, The risk or severity of QTc prolongation can be increased when Promethazine is combined with Fluorouracil.]
[C01BC03, propafenone, The metabolism of Fluorouracil can be decreased when combined with Propafenone.]
[L01XH02, romidepsin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Romidepsin.]
[N01AX10, propofol, The metabolism of Fluorouracil can be decreased when combined with Propofol.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Fluorouracil.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Propylthiouracil.]
[C01AB01, proscillaridin, Proscillaridin may decrease the cardiotoxic activities of Fluorouracil.]
[B01AC09, epoprostenol, The risk or severity of bleeding can be increased when Epoprostenol is combined with Fluorouracil.]
[R03DC03, montelukast, The metabolism of Fluorouracil can be decreased when combined with Montelukast.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Fluorouracil.]
[N05AX12, aripiprazole, The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Fluorouracil.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Fluorouracil.]
[R06AC01, pyrilamine, The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Fluorouracil.]
[P01BD01, pyrimethamine, The metabolism of Fluorouracil can be decreased when combined with Pyrimethamine.]
[C01BA01, quinidine, The metabolism of Fluorouracil can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Fluorouracil can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be decreased when combined with Fluorouracil.]
[J04AB02, rifampin, The metabolism of Fluorouracil can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Roxithromycin.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Fluorouracil.]
[N05CA06, secobarbital, The metabolism of Fluorouracil can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Fluorouracil can be decreased when combined with Selegiline.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Obinutuzumab.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Fluorouracil.]
[C07AA07, sotalol, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Sotalol.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Fluorouracil.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Fluorouracil.]
[C03DA01, spironolactone, The metabolism of Fluorouracil can be decreased when combined with Spironolactone.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Hydrocortisone butyrate.]
[L01CD03, paclitaxel poliglumex, The risk or severity of cardiotoxicity can be increased when Fluorouracil is combined with Paclitaxel poliglumex.]
[H02CA04, levoketoconazole, The metabolism of Fluorouracil can be decreased when combined with Levoketoconazole.]
